Cellarcus Biosciences, Inc.
La Jolla, CA · Biotech · Private
high-resolution assay kits for characterizing mesenchymal stromal cell-derived extracellular vesicles (number, size, surface cargo)
- Grants
- $6.7M
- 7 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2018201920202021202220232024
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase II · Identification of Cell Type-specific EVs for Neuroscience Research | $747,646 | |
| Federal grant | Department of Health and Human Services · Phase II · Identification of Cell Type-specific EVs for Neuroscience Research | $695,443 | |
| Federal grant | Department of Health and Human Services · Phase II · Assays and kits for MSC-derived extracellular vesicles | $755,409 | |
| Federal grant | Department of Health and Human Services · Phase II · Assays and kits for MSC-derived extracellular vesicles | $1,646,328 | |
| Federal grant | Department of Health and Human Services · Phase II · Assays and kits for MSC-derived extracellular vesicles | $890,919 | |
| Federal grant | Department of Health and Human Services · Phase II · Quantitative Analysis of Cancer-associated EVs | $1,008,320 | |
| Federal grant | Department of Health and Human Services · Phase II · Quantitative Analysis of Cancer-associated EVs | $991,680 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 3251 | MBC PHARMA, INC. | — | — |
| 3252 | OM BHARTI LLC | — | — |
| 3253 | Percept Corp | — | $4.8M |
| 3254 | Cellarcus Biosciences, Inc. | — | — |
| 3255 | General Beverage Consulting & Management, Inc. | — | $350K |
| 3256 | Antiger Therapeutics Inc. | — | — |
| 3257 | ADVANCED RNA TECHNOLOGIES, LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.